Polaris Quantum Biotech Study Demonstrates Quantum Advantage Over Generative AI in Drug Discovery

Polaris Quantum Biotech (PolarisQB) has released a comparative study indicating that its Quantum-Aided Drug Design (QuADD) platform, powered by D-Wave Quantum Inc.’s annealing technology, significantly outperforms classical Generative AI in lead identification for drug discovery. The study, currently a preprint on ChemRxiv, compared QuADD to the Bond and Interaction generating Diffusion model (BInD), a representative […]

The post Polaris Quantum Biotech Study Demonstrates Quantum Advantage Over Generative AI in Drug Discovery appeared first on Quantum Computing Report.